Nuevas formas de vehiculización de agentes hipotensores para el tratamiento del glaucoma
- Andres Guerrero, Vanessa
- María del Rocío Herrero Vanrell Director/a
- Irene Teresa Molina Martínez Director/a
Universidad de defensa: Universidad Complutense de Madrid
Fecha de defensa: 29 de junio de 2011
- Julián García Feijoo Presidente/a
- Beatriz de las Heras Polo Secretario/a
- Virginia Merino Sanjuán Vocal
- Nicolas Tsapis Vocal
- Carmen Álvarez Lorenzo Vocal
Tipo: Tesis
Resumen
Glaucoma is the second leading cause of blin dness in the world. It is a chronic optic neuropathy which can lead to complete loss of vision if an adequate treatment is not used in time. At the moment there is no cure for glaucoma and the available treatments are chronic and only manage to contr ol or decrease the evolution of the pathology. These types of treatments, consisting of the instillation of eye drops once or twice per day, are usually associated to short- and long-term adverse effects that compromise the patient compliance...